These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 37543582)

  • 41. Clinicopathological analysis of splenic red pulp low-grade B-cell lymphoma.
    Suzuki T; Miyoshi H; Shimono J; Kawamoto K; Arakawa F; Furuta T; Yamada K; Yanagida E; Takeuchi M; Seto M; Sone H; Takizawa J; Ohshima K
    Pathol Int; 2020 May; 70(5):280-286. PubMed ID: 32052529
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Molecular and therapeutic advances in Hairy cell leukemia].
    Balsat M; Cornillon J
    Bull Cancer; 2013 Oct; 100(10):1043-7. PubMed ID: 24103785
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Analysis of V600E BRAF and D816V KIT mutations in systemic mastocytosis.
    Hägglund H; Sander B; Ahmadi A; Gülen T; Nilsson G
    Med Oncol; 2014 Aug; 31(8):123. PubMed ID: 25034364
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hairy cell leukemia: 2020 update on diagnosis, risk stratification, and treatment.
    Maitre E; Cornet E; Troussard X
    Am J Hematol; 2019 Dec; 94(12):1413-1422. PubMed ID: 31591741
    [TBL] [Abstract][Full Text] [Related]  

  • 45. New insights in the management of patients with hairy cell leukemia.
    Cornet E; Damaj G; Troussard X
    Curr Opin Oncol; 2015 Sep; 27(5):371-6. PubMed ID: 26154707
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Metabolic Rewiring by Oncogenic BRAF V600E Links Ketogenesis Pathway to BRAF-MEK1 Signaling.
    Kang HB; Fan J; Lin R; Elf S; Ji Q; Zhao L; Jin L; Seo JH; Shan C; Arbiser JL; Cohen C; Brat D; Miziorko HM; Kim E; Abdel-Wahab O; Merghoub T; Fröhling S; Scholl C; Tamayo P; Barbie DA; Zhou L; Pollack BP; Fisher K; Kudchadkar RR; Lawson DH; Sica G; Rossi M; Lonial S; Khoury HJ; Khuri FR; Lee BH; Boggon TJ; He C; Kang S; Chen J
    Mol Cell; 2015 Aug; 59(3):345-358. PubMed ID: 26145173
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of methodologies for the detection of
    Cardus B; Colling R; Hamblin A; Soilleux E
    J Clin Pathol; 2019 Jun; 72(6):406-411. PubMed ID: 30872385
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Novelties in the diagnostics and therapy of hairy cell leukemia].
    Sári E; Rajnai H; Dénes K; Bödör C; Csomor J; Körösmezey G; Tárkányi I; Eid H; Nagy Z; Demeter J
    Magy Onkol; 2016 Jun; 60(2):137-44. PubMed ID: 27275640
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hematopoietic stem cell origin of BRAFV600E mutations in hairy cell leukemia.
    Chung SS; Kim E; Park JH; Chung YR; Lito P; Teruya-Feldstein J; Hu W; Beguelin W; Monette S; Duy C; Rampal R; Telis L; Patel M; Kim MK; Huberman K; Bouvier N; Berger MF; Melnick AM; Rosen N; Tallman MS; Park CY; Abdel-Wahab O
    Sci Transl Med; 2014 May; 6(238):238ra71. PubMed ID: 24871132
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hairy Cell Leukemia (HCL) and HCL Variant: Updates and Spotlights on Therapeutic Advances.
    Paillassa J; Maitre E; Troussard X
    Curr Oncol Rep; 2022 Sep; 24(9):1133-1143. PubMed ID: 35403971
    [TBL] [Abstract][Full Text] [Related]  

  • 51. BRAF mutation detection in hairy cell leukaemia from archival haematolymphoid specimens.
    Thomas C; Amanuel B; Finlayson J; Grieu-Iacopetta F; Spagnolo DV; Erber WN
    Pathology; 2015 Jun; 47(4):349-54. PubMed ID: 25938346
    [TBL] [Abstract][Full Text] [Related]  

  • 52. BRAF
    Tsai YT; Lozanski G; Lehman A; Sass EJ; Hertlein E; Salunke SB; Chen CS; Grever MR; Byrd JC; Lucas DM
    Leuk Res; 2015 Sep; ():. PubMed ID: 26350141
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical features and diagnosis of hairy cell leukemia.
    Quest GR; Johnston JB
    Best Pract Res Clin Haematol; 2015 Dec; 28(4):180-92. PubMed ID: 26614896
    [TBL] [Abstract][Full Text] [Related]  

  • 54. BRAF V600E is also seen in unclassifiable splenic B-cell lymphoma/leukemia, a potential mimic of hairy cell leukemia.
    Raess PW; Mintzer D; Husson M; Nakashima MO; Morrissette JJ; Daber R; Bagg A
    Blood; 2013 Oct; 122(17):3084-5. PubMed ID: 24159168
    [No Abstract]   [Full Text] [Related]  

  • 55. Biology and Treatment of Hairy Cell Leukemia.
    Paillassa J; Troussard X
    Curr Treat Options Oncol; 2020 Apr; 21(6):44. PubMed ID: 32350628
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hairy cell leukemia: a specific 17-gene expression signature points to new targets for therapy.
    Maitre E; Cornet E; Debliquis A; Drenou B; Gravey F; Chollet D; Cheze S; Docquier M; Troussard X; Matthes T
    J Cancer Res Clin Oncol; 2022 Aug; 148(8):2013-2022. PubMed ID: 35476232
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hairy Cell Leukemia, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.
    Wierda WG; Byrd JC; Abramson JS; Bhat S; Bociek G; Brander D; Brown J; Chanan-Khan A; Coutre SE; Davis RS; Fletcher CD; Hill B; Kahl BS; Kamdar M; Kaplan LD; Khan N; Kipps TJ; Lancet J; Ma S; Malek S; Mosse C; Shadman M; Siddiqi T; Stephens D; Wagner N; Zelenetz AD; Dwyer MA; Sundar H
    J Natl Compr Canc Netw; 2017 Nov; 15(11):1414-1427. PubMed ID: 29118233
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A case of concomitant chronic lymphocytic leukaemia and hairy cell leukaemia evaluated for IGHV-D-J rearrangements and BRAF-V600E mutation: lack of evidence for a common origin.
    Cavalli M; Ilari C; Del Giudice I; Marinelli M; Della Starza I; De Propris MS; De Novi LA; Nunes V; Cafforio L; Raponi S; Mancini F; Mauro FR; Tiacci E; Falini B; Guarini A; Foà R
    Br J Haematol; 2016 Jul; 174(2):329-31. PubMed ID: 26455504
    [No Abstract]   [Full Text] [Related]  

  • 59. Hairy cell leukemia - etiopathogenesis, diagnosis and modern therapeutic approach.
    Maćkowiak K; Jankowiak M; Szewczyk-Golec K; Hołyńska-Iwan I
    Biochem Med (Zagreb); 2024 Jun; 34(2):020502. PubMed ID: 38882583
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Phospho-ERK(THR202/Tyr214) is overexpressed in hairy cell leukemia and is a useful diagnostic marker in bone marrow trephine sections.
    Warden DW; Ondrejka S; Lin J; Durkin L; Bodo J; Hsi ED
    Am J Surg Pathol; 2013 Feb; 37(2):305-8. PubMed ID: 23211289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.